Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Marlene Chakhtoura(American University of Beirut Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Caline Rhayem(American University of Beirut Medical Center), Raya Tcheroyan(American University of Beirut), Malak Ghezzawi(American University of Beirut Medical Center), Rachelle Haber(American University of Beirut Medical Center)
Cited by 437
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k